ISPOR - New Drugs In Non-Small Cell Lung Cancer- Disparities In Requirements For Post-Launch Real-Word Evidence In Europe

Full Text

New Drugs In Non-Small Cell Lung Cancer- Disparities In Requirements For Post-Launch Real-Word Evidence In Europe

Abstract

Authors

D Floyd J Langham

Back to Volume 18, Issue 7

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now